Stenoparib | Interleukin Related interleukin-related.com

Product Name :
Stenoparib

Search keywords :
Stenoparib

drugId :
null

Target Vo:
Poly (ADP-Ribose) Polymerase 2

Target Vo Short Name :
PARP-2

Moa_Name:
Poly (ADP-Ribose) polymerase 1 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Eisai Co Ltd

Active Company_Name :
Allarity Therapeutics A/S

Active Indication_Name:
Ovarian Neoplasms

In Active Indication_Name:
Melanoma

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Labetuzumab govitecan custom synthesis
Obiltoxaximab Epigenetic Reader Domain
Cleaved PARP Antibody: Cleaved PARP Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 89 kDa, targeting to Cleaved PARP. It can be used for WB,ICC,IP,FC assays with tag free, in the background of Human.

Author: Interleukin Related

Related Posts